r. Eli Zavialov, Scientific Director, Regulatory CMC Dossier Development at J&J. Eli joined Johnson & Johnson in 2011, where he has made significant contributions to the preparation and delivery of technical CMC sections to support global clinical trial and marketing applications across a diverse portfolio of biologics and small molecules. In his current role, Eli serves as a single point of contact for GRA CMC senior leadership on strategic dossier needs and requirements. Eli is accountable for working in close partnership with GRA CMC and matrix functions to ensure that dossier submission projects are aligned with key stakeholder requirements. Prior to joining Johnson & Johnson, Eli worked in Chemical Development and Technical Operations at Merck and Schering-Plough in various positions of increasing responsibility. Eli holds a Ph.D. Degree in Organic & Bioorganic Chemistry for the University of Southern California, Los Angeles, CA, and B.Sc. Degree in Chemistry from the Moscow State University, Moscow, Russia.